Skip to search formSkip to main contentSkip to account menu

hyperviscosity syndrome

Known as: hyperviscosity syndromes 
National Institutes of Health

Related topics

Related topics

4 relations
HYPERGLOBULINEMIA SYNDROMEWaldenstrom Macroglobulinemia

Broader (2)

Hematological DiseaseSyndrome

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2011
Highly Cited
2011
Placental Insufficiency and Fetal Growth Restriction
ObjectivesFetal growth restriction is defined as a pathologic decrease in the rate of fetal growth. The most frequent etiology… 
Review
2003
Review
2003
Therapeutic apheresis in Sweden: update of epidemiology and adverse events.
Review
2003
Review
2003
Correction of hyperviscosity by apheresis.
Therapeutic apheresis is an extracorporeal blood purification technique designed for the removal of either plasma (plasmapheresis… 
Review
1999
Review
1999
The Hyperviscosity Syndromes
Impaired blood flow due to abnormal rheologic characteristics results in a multiplicity of clinical manifestations, collectively… 
Highly Cited
1997
Highly Cited
1997
Iatrogenic central retinal vein occlusion and hyperviscosity associated with high-dose intravenous immunoglobulin administration.
Highly Cited
1990
Highly Cited
1990
Waldenstrom's macroglobulinemia presenting with pleuropulmonary and gastric manifestations.
A case of Waldenstrom's macroglobulinemia is reported in which the main clinical presentation was related to pulmonary… 
Review
1988
Review
1988
Vertigo in the Hyperviscosity Syndrome
Diseases that cause hyperviscosity of the blood can result in otologic symptoms—especially vertigo. These symptoms are… 
Highly Cited
1982
Highly Cited
1982
Developmental and neurologic sequelae of neonatal hyperviscosity syndrome.
One hundred eleven consecutive infants with neonatal hyperviscosity were identified by screening all newborns for polycythemia in… 
Highly Cited
1972
Highly Cited
1972
IgA pyroglobulin, hyperviscosity syndrome and coagulation abnormality in a patient with multiple myeloma.
A 48-yr-old woman with a bleeding diathesis and complaining of blurred vision, headache, paresthesias, and vomoting was diagnosed… 
Review
1967
Review
1967
The treatment of plasma cell myeloma.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)